Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.22.1 (
DNase II
)
429
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The structure of the human gene for
deoxyribonuclease II
(
DNase II
;
EC 3.1.22.1
) was determined using several specific primers based on the human
DNase II
cDNA sequence [Yasuda et al. (1998). J. Biol. Chem. 273, 2610-2616] in a polymerase chain reaction-based strategy. The gene spanned about 6 kb and consisted of 6 exons. No canonical TATA or CAAT boxes could be identified within the 1341 nucleotides upstream of the putative transcription start site, although the 5'-flanking region contained a CpG island and several putative binding motifs for transcription factors
Sp1
and ETF. These properties indicate that the
DNase II
gene is a housekeeping gene and this is compatible with its ubiquitous expression in human tissues. Three different cleavage/polyadenylation sites were identified in the 3'-flanking region, leading to the production of multiple
DNase II
mRNA species. However, a comparison of the entire translated sequences of the gene from a pair of subjects with homozygous
DNase II
phenotypes H and L revealed no differences in the nucleotide sequences.
...
PMID:Structure and organization of the human deoxyribonuclease II (DNase II) gene. 992 8
Expression of
DNase II
in macrophages is potentially crucially important in the removal of unwanted DNA. We have previously shown that
DNase II
expression is up-regulated at the transcriptional level during the phorbol 12-myristate-13-acetate (PMA)-induced differentiation of HL-60 and THP-1 cells. In this study, we investigated the cis-regulatory elements and transcription factors involved in this process in HL-60 cells. cis-Regulatory elements in the
DNase II
promoter were located by 5' deletion and site-directed mutagenesis of promoter-luciferase constructs and transient transfection of HL-60 cells. Furthermore, the binding proteins were identified by electrophoretic mobility shift assay (EMSA) in the presence of specific antibodies. In the
DNase II
promoter, 249 base pairs upstream of the transcription start site were essential for maximal promoter activity in both untreated and PMA-treated HL-60 cells and, within this region, three
Sp1
and Sp3 binding sites were identified as essential for transcriptional regulation and PMA induction. Western blot analysis showed that PMA treatment resulted in increased levels of
Sp1
and Sp3 proteins. Furthermore, cotransfection analysis in Drosophila SL2 cells showed that
Sp1
was more potent than Sp3 in activating the
DNase II
promoter. We therefore conclude that
Sp1
and/or Sp3 are involved in the up-regulation of
DNase II
expression during the differentiation of HL-60 cells.
...
PMID:Sp1 and Sp3 are involved in up-regulation of human deoxyribonuclease II transcription during differentiation of HL-60 cells. 1269 99